Rob B van der Luijt
Overview
Explore the profile of Rob B van der Luijt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
4430
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van der Tuin K, Ruano D, Knijnenburg J, van der Luijt R, Morreau H, Links T, et al.
J Clin Endocrinol Metab
. 2024 Feb;
109(12):e2214-e2221.
PMID: 38415346
Context: The underlying genetic cause of nonmedullary thyroid cancer (NMTC) in children is often unknown, hampering both predictive testing of family members and preventive clinical management. Objective: Our objectives were...
2.
Dumont M, Weber-Lassalle N, Joly-Beauparlant C, Ernst C, Droit A, Feng B, et al.
Cancers (Basel)
. 2022 Jul;
14(14).
PMID: 35884425
Rare variants in at least 10 genes, including BRCA1, BRCA2, PALB2, ATM, and CHEK2, are associated with increased risk of breast cancer; however, these variants, in combination with common variants...
3.
Velthuizen M, van der Luijt R, de Vries B, Koudijs M, Bleiker E, Ausems M
Hered Cancer Clin Pract
. 2021 Jan;
19(1):9.
PMID: 33468213
Background: CHEK2 has been recognized as a breast cancer risk gene with moderate effect. Women who have previously tested negative for a BRCA1/2 gene germline pathogenic variant may benefit from...
4.
Patel V, Busch E, Friebel T, Cronin A, Leslie G, McGuffog L, et al.
Cancer Res
. 2019 Nov;
80(3):624-638.
PMID: 31723001
Pathogenic sequence variants (PSV) in or () are associated with increased risk and severity of prostate cancer. We evaluated whether PSVs in were associated with risk of overall prostate cancer...
5.
Beijers H, Stikkelbroeck N, Mensenkamp A, Pfundt R, van der Luijt R, Timmers H, et al.
Eur J Endocrinol
. 2018 Nov;
180(2):K15-K19.
PMID: 30481156
Context Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disease caused by mutations in the tumor suppressor gene MEN1 and can be diagnosed based on clinical, familial and/or...
6.
Teixeira N, van der Hout A, Oosterwijk J, Vos J, Devilee P, van Engelen K, et al.
Eur J Hum Genet
. 2018 Feb;
26(6):848-857.
PMID: 29483665
This observational study aimed to investigate whether the reported association between family history (FH) of breast cancer (BC) or ovarian cancer (OC) and OC risks in BRCA1/2 mutation carriers can...
7.
Rebbeck T, Friebel T, Friedman E, Hamann U, Huo D, Kwong A, et al.
Hum Mutat
. 2018 Feb;
39(5):593-620.
PMID: 29446198
The prevalence and spectrum of germline mutations in BRCA1 and BRCA2 have been reported in single populations, with the majority of reports focused on White in Europe and North America....
8.
Michailidou K, Lindstrom S, Dennis J, Beesley J, Hui S, Kar S, et al.
Nature
. 2017 Oct;
551(7678):92-94.
PMID: 29059683
Breast cancer risk is influenced by rare coding variants in susceptibility genes, such as BRCA1, and many common, mostly non-coding variants. However, much of the genetic contribution to breast cancer...
9.
Moghadasi S, Meeks H, Vreeswijk M, Janssen L, Borg A, Ehrencrona H, et al.
J Med Genet
. 2017 May;
55(1):15-20.
PMID: 28490613
Background: We previously showed that the variant c.5096G>A p.Arg1699Gln (R1699Q) was associated with an intermediate risk of breast cancer (BC) and ovarian cancer (OC). This study aimed to assess these...
10.
Phelan C, Kuchenbaecker K, Tyrer J, Kar S, Lawrenson K, Winham S, et al.
Nat Genet
. 2017 Mar;
49(5):680-691.
PMID: 28346442
To identify common alleles associated with different histotypes of epithelial ovarian cancer (EOC), we pooled data from multiple genome-wide genotyping projects totaling 25,509 EOC cases and 40,941 controls. We identified...